2,3-dihydrobenzohurans as bromodomain inhibitors
US11319307B2 · kind B2 · utility
0Cited by
1References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 4, 2018 |
| Grant date | May 3, 2022 |
| Priority date | — |
| Expiry date | Oct 4, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.